Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00333463 · ClinicalTrials.gov registry record

Compliance With Once Daily Glaucoma Medication

A clinical trial, sponsored by Alcon Research.

Completed
Registry status
700
Enrollment target

NCT00333463: Completed study, sponsored by Alcon Research.

NCT00333463 is a clinical trial that has completed, run by Alcon Research. The registered enrollment target is 700 participants. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00333463 has completed, sponsored by Alcon Research.

COMPLETED
Registry status
700 participants
Enrollment target

Study Summary

A study to examine patient compliance with once daily glaucoma medication

Interventions

  • BEHAVIORAL Intervention

Trial Details

FieldValue
Enrollment Target 700 participants
Start Date 2006-06
Est. Completion 2007-09
Alcon Research

275 total trials

What the finished NCT00333463 record still lists

NCT00333463 is an observational study that tracks outcomes without assigning an intervention. The registered 700 participants enrollment target is mid-sized for trials with a published cap.

The record links to 0 conditions, and to 1 intervention - of which Intervention is the first listed.

NCT00333463 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT00333463 about?

NCT00333463 is a clinical study titled "Compliance With Once Daily Glaucoma Medication". A study to examine patient compliance with once daily glaucoma medication

What is the current status of trial NCT00333463?

This trial is currently completed. The enrollment target is 700 participants. The study started on 2006-06. Estimated completion is 2007-09.

What interventions are being tested in trial NCT00333463?

The interventions under investigation include: Intervention (BEHAVIORAL).

Who is sponsoring clinical trial NCT00333463?

This trial is sponsored by Alcon Research, which has 275 total clinical trials registered on ClinicalTrials.gov.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00900419 · 700 participants

    Biomarkers in Patients With Respiratory Tract Dysplasia or Lung Cancer, Head and Neck Cancer, or Aerodigestive Tract Cancer and in Normal Volunteers

  • NCT01804686 · 700 participants · Phase 3

    A Long-term Extension Study of PCI-32765 (Ibrutinib)

  • NCT02107989 · 700 participants

    Noninvasive Pre-surgical Evaluation of Patients With Focal Epilepsy and Establishment of a Normative Imaging Database

  • NCT02129543 · 700 participants

    Immune Reconstitution in Stem Cell Transplant Recipients

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT00333463, the US trial registry maintained by the National Library of Medicine. NCT00333463 (mid enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.